Cart (0 Items)
Your cart is currently empty.
View ProductsHuman CD270,TNFRSF14,HVEM recombinant protein
| Size | 100ug, 50ug |
|---|---|
| Brand | |
| Product type | |
| Host Species | |
| Applications |
| Product name | Human CD270,TNFRSF14,HVEM recombinant protein |
|---|---|
| Uniprot ID | Q92956 |
| Uniprot link | http://www.uniprot.org/uniprot/Q92956 |
| Origin species | Homo sapiens (Human) |
| Expression system | Eukaryotic expression |
| Sequence | MEPPGDWGPPPWRSTPKTDVLRLVLYLTFLGAPCYAPALPSCKEDEYPVGSECCPKCSPGYRVKEACGELTGTVCEPCPPGTYIAHLNGLSKCLQCQMCDPAMGLRASRNCSRTENAVCGCSPGHFCIVQDGDHCAACRAYATSSPGQRVQKGGTESQDTLCQNCPPGTFSPNGTLEECQHQTKCSWLVTKAGAGTSSSHWVGSHHHHHH |
| Molecular weight | 22.46kDa |
| Protein delivered with Tag? | Yes |
| Purity estimated | 40% |
| Buffer | PBS, pH 7.5 |
| Form | Lyophilized |
| Delivery condition | Dry Ice |
| Delivery lead time in business days | 5-7 |
| Storage condition | 4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection) |
| Brand | ProteoGenix |
| Host species | Mammalian cells |
| Applications | ELISA,WB |
| Fragment Type | Partial |
| Aliases /Synonyms | Tumor necrosis factor receptor superfamily member 14,Herpes virus entry mediator A,Herpesvirus entry mediator A,HveA,Tumor necrosis factor receptor-like 2,TR2,D270 |
| Reference | PX-P4039 |
| Note | For research use only |
Related products
Biosimilar
Pidilizumab Biosimilar – Anti-PDCD1, CD279 mAb – Research Grade
PX-TA1312 400€
Biosimilar
Varlilumab Biosimilar – Anti-CD27, TNFRSF7 mAb – Research Grade
PX-TA1352 400€
Biosimilar
Atezolizumab Biosimilar – Anti-CD274, B7-H1, PDL1 mAb – Research Grade
PX-TA1367 300€
Biosimilar
Enoblituzumab Biosimilar – Anti-CD276, B7-H3 mAb – Research Grade
PX-TA1410 400€
Biosimilar
Prezalumab Biosimilar – Anti-ICOSLG, B7-H2, B7RP-1, CD275 mAb – Research Grade
PX-TA1417 400€
Biosimilar
Camrelizumab Biosimilar – Anti-PDCD1, PD-1, CD279 mAb – Research Grade
PX-TA1445 300€
Biosimilar
Gilvetmab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
PX-TA1467 400€
Biosimilar
Tislelizumab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
PX-TA1479 400€
Biosimilar
Spartalizumab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
PX-TA1483 300€
Biosimilar
Vopratelimab Biosimilar – Anti-ICOS, CD278 mAb – Research Grade
PX-TA1505 400€
Biosimilar
Cetrelimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
PX-TA1513 400€
Biosimilar
Budigalimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
PX-TA1523 400€
Biosimilar
Cemiplimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
PX-TA1524 400€
Biosimilar
Dostarlimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
PX-TA1526 400€
Ligand
Reviews
Il n’y a pas encore d’avis.